NIH-funded research R01 grant

Using glial cells to reduce visceral pain in bladder conditions

Official title: Activating Peripheral Glia to Relieve Visceral Pain in Animal Models of Urological Chronic Pelvic Pain Syndrome (UCPPS)

Funded at University of Colorado Denver · NIH-11140281 · Data updated 2026-11-12

This study is looking at how certain cells in the nervous system can be activated to help reduce the pain that comes with chronic pelvic pain syndrome, especially for those dealing with bladder issues, and it aims to find new treatment options that could eventually help people like you.

More Pelvic Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJuly 19, 2021
Project endMay 31, 2026
Funding year2025
Award (this year)$342,100
NIH project number5R01DK129260-05
Project IDNIH-11140281 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing chronic pelvic pain or bladder dysfunction, particularly those with urological chronic pelvic pain syndrome.

Less likely to help

Patients with acute pain conditions or those not suffering from bladder-related issues may not benefit from this research.

What this research studies

This research investigates how specific glial cells in the peripheral nervous system can be activated to help alleviate visceral pain associated with urological chronic pelvic pain syndrome. By focusing on satellite glial cells, the study aims to understand their role in regulating sensory neuron activity and how they contribute to pain sensations. The researchers will explore signaling pathways that could be targeted for gene therapies, potentially leading to new treatments for bladder dysfunction and related pain. The approach involves testing these mechanisms in animal models to gather insights that could translate into human therapies.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that significantly reduce visceral pain and improve bladder function for patients suffering from chronic pelvic pain.

How similar studies have gone: Previous research has shown promising results in targeting glial cells for pain management, suggesting that this approach could be effective, although it is still an emerging area of study.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Xie, Xiaoqiao — University of Colorado Denver
  • Study coordinator: Xie, Xiaoqiao

Related research

Other NIH-funded projects on the same topics.

  • Exploring allergy-based triggers to prevent UCPPS flare-ups

    A short, patient-friendly study will look at whether allergy-related antibodies can help predict and prevent flare-ups in people with urologic chronic pelvic pain syndrome.

    NIH research Washington University · Saint Louis, United States · NIH-11445166

  • Dual Cromolyn-Cetirizine oral capsule to help men with chronic pelvic pain

    A new oral medicine combining cromolyn sodium and cetirizine is being developed to help adults with chronic prostatitis/chronic pelvic pain by targeting immune and nerve-related pathways.

    NIH research Dolor Therapeutics, LLC · Chicago, United States · NIH-11407121

  • A brief behavioral treatment for chronic pelvic pain

    This project is testing a short behavioral therapy to help people manage chronic pelvic pain and related conditions like irritable bowel syndrome.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11159501

  • Chemical Clues in Chronic Pelvic Pain

    This project looks for unique chemical patterns in the body that could help us better understand and treat chronic pelvic pain in men and women.

    NIH research Washington University · Saint Louis, United States · NIH-11143622

  • Improving treatment for chronic pelvic pain in men

    This study is looking to create a new oral medication to help men under 50 who suffer from chronic prostatitis/chronic pelvic pain syndrome, by combining two types of medicine that have shown promise, and it will first test these new formulas in dogs to find the best one before trying it in people.

    NIH research Dolor Therapeutics, LLC · Chicago, United States · NIH-10918611

  • Investigating the role of food-specific antibodies in chronic pelvic pain conditions.

    This study is looking at how certain foods might affect people with chronic pelvic pain, like interstitial cystitis and chronic prostatitis, to find out if changing what you eat can help ease your symptoms.

    NIH research Washington University · Saint Louis, United States · NIH-10914073

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.